desipramine has been researched along with adenosine 5'-o-(3-thiotriphosphate) in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Starke, K; Stoffel, D; von Kügelgen, I | 1 |
Koch, H; Starke, K; von Kügelgen, I | 1 |
2 other study(ies) available for desipramine and adenosine 5'-o-(3-thiotriphosphate)
Article | Year |
---|---|
P2-purinoceptor-mediated inhibition of noradrenaline release in rat atria.
Topics: Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Antihypertensive Agents; Atropine; Desipramine; Dose-Response Relationship, Drug; Electric Stimulation; Heart Atria; Indomethacin; Male; Norepinephrine; Phenethylamines; Protein Synthesis Inhibitors; Purinergic P1 Receptor Antagonists; Purinergic P2 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Receptors, Purinergic P2; Suramin; Triazines; Xanthines; Yohimbine | 1995 |
P2-receptor-mediated inhibition of serotonin release in the rat brain cortex.
Topics: 2-Chloroadenosine; Adenosine; Adenosine Triphosphate; Adenosine-5'-(N-ethylcarboxamide); Animals; Cerebral Cortex; Desipramine; Dinucleoside Phosphates; In Vitro Techniques; Male; Methiothepin; Quipazine; Rats; Rats, Wistar; Receptors, Purinergic P2; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists | 1997 |